ClinicalTrials.Veeva

Menu
O

Oviedo Medical Research | Oviedo, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Semaglutide
Tirzepatide
Metformin
LY3298176
Testosterone Undecanoate
Cagrilintide
Sugar
JZP-110
Linaclotide
LPCN 1021

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 44 total trials

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight....

Begins enrollment this month
Obesity
Type 2 Diabetes
Drug: Cagrisema
Drug: Semaglutide

This study will look at how well CagriSema helps people living with obesity to lose weight and maintain the weight loss long-term. The study has 2 pa...

Active, not recruiting
Obesity
Drug: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)
Drug: CagriSema (Cagrilintide B and Semaglutide I)

The purpose of this study is to measure the change in hemoglobin A1c (HbA1c) with LY3457263 compared with placebo in participants with type 2 diabete...

Enrolling
Type 2 Diabetes
Drug: LY3457263
Drug: Placebo
Locations recently updated

This is a parallel, double blind, Phase 3, 2-arm study that is designed to provide additional safety information, assess the durability of treatment...

Active, not recruiting
Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: Itepekimab (SAR440340)
Locations recently updated

The purpose of this clinical study is to learn about the safety and effects of the study medicine to help adults with obesity or overweight and type...

Enrolling
Overweight and/or Obesity
Overweight
Drug: PF-08653944
Other: Placebo
Locations recently updated

The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight and type 2 di...

Enrolling
Overweight
Diabetes Mellitus
Drug: NNC0487-0111
Drug: Placebo (matched to NNC0487-0111)
Locations recently updated

This study investigates the efficacy and safety of once weekly injectable MET097 in adult participants with obesity or overweight with weight-related...

Enrolling
Obesity and Overweight
Drug: Placebo
Drug: MET097

Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Placebo
Drug: Inclisiran sodium 300 mg

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this study is...

Enrolling
Asthma
Drug: Budesonide/Albuterol
Drug: Lunsekimig

This study will look at how much cagrilintide helps people with overweight or obesity lower their body weight. Cagrilintide is a new investigational...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Cagrilintide

Trial sponsors

Novo Nordisk logo
Lilly logo
Pfizer logo
Sanofi logo
AbbVie logo
Eisai logo
G
Jazz Pharmaceuticals logo
M
Bayer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems